Nonalcoholic fatty liver disease (NAFLD) is now the leading cause of chronic liver disease
worldwide with a strong association with metabolic syndrome. NAFLD is truly a systemic …

Nonalcoholic fatty liver disease (NAFLD) affects about a third of the world's adult population
and is a major public health concern. NAFLD is defined by the presence of hepatic steatosis …

Non-alcoholic fatty liver disease (NAFLD) is present in up to one-third of the general
population and in the majority of patients with cardio-metabolic risk factors such as …

Studies have shown that nonalcoholic fatty liver disease (NAFLD) is strongly associated with
several metabolic disorders and diseases, such as obesity, type 2 diabetes mellitus, and …

Recognition of the link between non‐alcoholic fatty liver disease (NAFLD) and
cardiovascular disease (CVD) has boosted research in this area. The main objective of this …

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease throughout the
world. Pathophysiological insights into this disease have recently illustrated that various …

A number of recent reports have raised alarm about the link between nonalcoholic fatty liver
disease (NAFLD) and cardiovascular risk [1▪▪, 2▪, 3, 4]. Worry appears justified as the …

Nonalcoholic fatty liver disease (NAFLD) is a growing epidemic in the USA affecting∼ 30%
of the population. It has been closely linked to metabolic syndrome and type 2 diabetes, with …

An association between non-alcoholic fatty liver disease (NAFLD) and cardiovascular
disease (CVD) has been recently suggested. Indeed, different studies have demonstrated …

Nonalcoholic fatty liver disease (NAFLD) is a systemic disorder with a complex multifactorial
pathogenesis and heterogenous clinical manifestations. NAFLD, once believed to be an …